Osteo Bi-Flex
Osteo Bi-Flex Ease
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
19
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
3 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Vitamin D UNII · 9VU1KI44GP | 10 mcg | 50% |
| Joint Shield 5-Loxin Advanced Boswellia serrata extract Boswellia | 100 mg | — |
| UC-II Standardized Cartilage Cartilage | 40 mg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxide colorcolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
19
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Calcium Carbonate · Cellulose · Cellulose Coating · Stearic Acid · Croscarmellose · Polydextrose · Contains Less Than 2% of
Chemically equivalent
Same formula, different brand
Products with identical sorted (ingredient, amount) tuples.